Image

Ammoren Dohm, MD

Radiation Oncologist

Genitourinary

Head & Neck

Lung

Myeloma & Lymphoma

Dr. Ammoren Dohm is a distinguished board-certified radiation oncologist serving the Greater Phoenix community with a deep commitment to providing patients with personalized cancer care. Dr. Dohm received a full-tuition academic scholarship to attend Wake Forest School of Medicine, where he earned his Doctor of Medicine (MD). He then completed residency at the Moffitt Cancer Center, an NCI-designated Cancer Center and the third largest cancer center in the United States. This rigorous training provided Dr. Dohm with unparalleled experience in cutting-edge radiation therapy techniques including adaptive radiotherapy, IMRT/IGRT, SBRT, radiosurgery, and HDR brachytherapy. Additionally, he has conducted research and published on radiotherapy combined with immunotherapy, radiation toxicity, and radiosurgery for brain metastases.

Dr. Dohm utilizes state-of-the-art technology and evidence-based practices to treat a variety of cancers including:   breast, brain, prostate, lung, head and neck cancers, among others. He believes in a collaborative, patient-centered approach to cancer treatment, involving patients in every step of their treatment plan and providing unwavering support throughout their cancer journey to deliver the highest quality care.

Present Title & Subspecialties

Title

Radiation Oncology

Subspecialties

GenitourinaryHead & NeckLungMyeloma & Lymphoma

Education & Training

Medical School

Wake Forest School of Medicine, Winston-Salem, North Carolina

Fellowships

Moffitt Cancer Center, Tampa, Florida
Cancers Treated
Certifications & Professional Memberships

  • American Society for Radiation Oncology
  • American Radium Society
  • American College of Radiotherapy and Oncology
  • Radiological Society of North America
  • Association of Residents in Radiation Oncology
  • American Medical Association
  • American Board of Radiology

Publications

Dohm AE, Nakashima JY, Kalagotla, H…Ahmed, KA. Stereotactic Radiosurgery and Anti-PD-1 + CTLA- 4  Therapy,  Anti-PD-1  Therapy,  Anti-CTLA-4  Therapy,  BRAF/MEK  Inhibitors,  BRAF  Inhibitors,  or  Conventional Chemotherapy for the Management of Melanoma Brain Metastases. Eur J Cancer. 2023  Aug 7. 

 

Dohm AE, Tang JD, Mills MN, Perez B, Robinson TJ, Creelan B, …Ahmed KA. Clinical outcomes of  non–small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune  checkpoint  inhibitors,  EGFR  tyrosine  kinase  inhibitors,  chemotherapy  and  immune  checkpoint  inhibitors, or chemotherapy alone. J Neurosurg. 2022 Nov 11. PMID: 36681988.

 

Dohm AE, Oliver DE, Michael Yu HH, Ahmed KA. Commentary: From Postoperative to Preoperative:  A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for  Brain Metastases. Oper Neurosurg (Hagerstown). 2022 Apr 11. PMID: 35404318.

 

Sandoval ML, Dohm AE, Yamoah K. Management of early-stage metastatic prostate cancer:  appraisal of locoregional treatments and radiation therapy, with or without immunomodulation.  Endocr Relat Cancer. 2021 Jul 15;28(8):T109-T120. PMID: 34061766.

 

Dohm AE, Nickles TM, Miller CE, Bowers HJ, Miga MI, Attia A, Chan MD, Weis JA. Clinical  assessment of a biophysical model for distinguishing tumor progression from radiation necrosis. Med  Phys. 2021 Jul;48(7):3852-3859. PMID: 34042188.

 

Dohm AE, Diaz R, Nanda RH. The Role of Radiation Therapy in the Older Patient. Curr Oncol Rep. 2021 Jan 2;23(1):11. PMID: 33387104.

 

Helis CA, Hughes RT, Glenn CW, Lanier CM, Masters AH, Dohm AE, Ahmed T, Ruiz J, Triozzi P,  Gondal H, Cramer CK, Tatter SB, Laxton AW, Xing F, Lo HW, Su J, Watabe K, Wang G, Whitlow CT,  Chan MD. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic  Radiosurgery and Immune Checkpoint Inhibitor Therapy. Int J Radiat Oncol Biol Phys. 2020 Sep  1;108(1):295-303. PMID: 32615262.

 

Dohm AE, Su J, McTyre ER, Taylor JM, Miller LD, Petty WJ, Xing F, Lo HW, Metheny-Barlow LJ,  O’Neill S, Bellinger C, Dotson T, Pasche B, Watabe K, Chan MD, Ruiz J. Identification of CD37, cystatin  A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial. Int  J Biol Markers. 2019 Mar;34(1):90-97. PMID: 30854931.

 

Dohm AE, Hughes R, Wheless W, Lecompte M, Lanier C, Ruiz J, Watabe K, Xing F, Su J, Cramer C,  Laxton A, Tatter S, Chan MD. Surgical resection and postoperative radiosurgery versus staged  radiosurgery for large brain metastases. J Neurooncol. 2018 Dec;140(3):749-756. PMID: 30367382.

 

Randolph DM, McTyre E, Klepin H, Peiffer AM, Ayala-Peacock D, Lester S, Laxton AW, Dohm AE,  Tatter SB, Shaw EG, Chan MD. Impact of radiosurgical management of geriatric patients with brain metastases: Clinical and quality of life outcomes. J Radiosurg SBRT. 2017;5(1):35-42. PMID: 29296461.

 

Dohm AE, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT,  Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD. Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique. Neurosurgery. 2018 Jul 1;83(1):114-121. PMID: 28973432.

 

Dohm AE, McTyre ER, Chan MD, Fan C, Isom S, Bourland JD, Mott RT, Cramer CK, Tatter SB,  Laxton  AW.  Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control. J Clin Neurosci. 2017 Dec;46:90-98. PMID:  28917587.

Honors & Awards

2022:  Clinical Science Abstract Award Winner, Moffitt Scientific Symposium

2019:  Clinical Science Featured Poster, Moffitt Scientific Symposium

2015-2019:  Resident Basic Science Research Award, American Society for Radiation Oncology

2015-2019:  Bowmen and James Gray Scholar, Wake Forest School of Medicine

CV
Videos

No videos found.

Languages

Location

Glendale

5810 W. Beverly Ln

Glendale, AZ 85306

Hours:

Monday- Friday

8am-5pm

Contact
(623) 312-3000
(623) 312-3060
Scottsdale

8880 E. Desert Cove Ave.

Scottsdale, AZ 85260

Hours:

Monday-Friday

8am-5pm

Contact
(480) 314-6670
480-257-1997
pixel